NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Physiology/Neuromuscular Junction
    Neuromuscular Junction
    medium
    heart-pulse Physiology

    A 58-year-old woman from Delhi presents with progressive ptosis and diplopia for 3 weeks. She reports worsening of symptoms towards evening and improvement after rest. On examination, she has bilateral ptosis, ophthalmoplegia, and mild proximal limb weakness. Repetitive nerve stimulation shows a decremental response. Serology is positive for anti-acetylcholine receptor (AChR) antibodies. What is the primary pathophysiological mechanism underlying her neuromuscular dysfunction?

    A. Blockade of acetylcholine release from the presynaptic terminal
    B. Inhibition of acetylcholinesterase enzyme activity
    C. Defective synthesis and packaging of acetylcholine in synaptic vesicles
    D. Autoimmune destruction of acetylcholine receptors at the neuromuscular junction

    Explanation

    ## Pathophysiology of Myasthenia Gravis **Key Point:** Myasthenia gravis (MG) is an autoimmune disorder where IgG antibodies bind to acetylcholine receptors (AChR) at the neuromuscular junction, leading to their destruction and blockade. ### Mechanism of AChR Antibody-Mediated Damage 1. **Antibody binding** — Anti-AChR IgG antibodies bind to the extracellular domain of AChR 2. **Complement activation** — Leads to complement-mediated lysis of the postsynaptic membrane 3. **Cross-linking and internalization** — Antibodies cross-link AChRs, promoting their endocytosis and degradation 4. **Functional blockade** — Even unbound receptors are functionally blocked by antibodies ### Clinical Correlation with Findings | Feature | Mechanism | |---------|----------| | Ptosis & diplopia | Ocular muscles affected early (lower safety margin) | | Fatigue with activity | Reduced available AChRs; acetylcholine cannot activate sufficient receptors | | Improvement with rest | Acetylcholine accumulates; some receptors recover | | Decremental response on RNS | Progressive failure of neuromuscular transmission with repeated stimulation | | Positive anti-AChR antibodies | Confirms autoimmune etiology (present in ~85% of generalized MG) | **High-Yield:** The safety margin of neuromuscular transmission is reduced because fewer functional AChRs are available. Ocular muscles are affected first because they have the lowest safety margin (~3-fold vs. limb muscles with ~5–6-fold). **Clinical Pearl:** Edrophonium (anticholinesterase) would temporarily improve symptoms by increasing acetylcholine concentration, but this patient's primary defect is receptor availability, not enzyme activity. ### Why This Is Not the Other Mechanisms - **Presynaptic blockade** (Lambert-Eaton syndrome) would show facilitation on high-frequency RNS, not decremental response - **Acetylcholinesterase inhibition** would cause excessive acetylcholine accumulation and cholinergic crisis - **Defective ACh synthesis** would present with congenital myasthenic syndromes, not seropositivity [cite:Guyton & Hall Textbook of Medical Physiology 14e Ch 8]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Physiology Questions